and its longest open reading frame product, polyductin, also known as fibrocystin, is a single transmembrane domain glycoprotein with a molecular weight of more than 440 kD in its unglycosylated form [5] .
A fusion protein containing the polyductin's intracellular carboxy-terminus, FP2, was previously used as a target to generate a polyclonal antibody that was applied to study the polyductin expression profile in human tissues [6] . The anti-FP2 purified antiserum stains the renal collecting ducts and thick ascending limbs of Henle in humans and the branching ureteric bud in mouse. Specific staining was also detected in murine intrahepatic and extrahepatic biliary system [7, 8] . The [9, 10] [11] . [12] . [13, 14] . Lack of remodelling of the primitive biliary system results in the persistence of an excess of embryonic bile duct structures. This abnormality has been termed the DPM [15] .
. Although controversially discussed, biliary disorders with or without metabolic diseases may show an increased risk to develop cancer (more commonly cholangiocellular carcinoma (CCC) than hepatocellular carcinoma (HCC))

CCC can arise in solitary cysts of the liver and has been reported in CHF, Caroli's disease, von Meyenburg complexes and polycystic liver disease. Other reported associations of CCC with biliary disorders include choledochal cyst, primary sclerosing cholangitis, and biliary atresia (BA). The cancer may arise either in the cyst wall itself, or in remnant tissue or undilated parts of the extrahepatic or intrahepatic biliary system
During liver development, liver progenitors differentiate into hepatocytes or biliary cells and data seem favour the notion that the segregation between hepatocytes and biliary cells is dependent on a gradient of Activin/TGFbeta signalling, and an aberrant and/or excessive differentiation by activin/TGFbeta signalling is at the basis of the abnormality of development of the intrahepatic biliary system
In
the current work, we investigated its expression pattern in foetal, neonatal, infantile disease states and adult hepatobiliary carcinomas. Our findings suggest that polyductin may be involved in the origin of the intrahepatic biliary system and that specific insults may lead to its increased expression during different phases of organogenesis. This proposed model might provide consequential information to better understand biliary dysgenesis.
Materials and methods
Definitions
The intrahepatic bile ducts develop out of primitive hepatic epithelial cell sheets and are mostly determined by the progressive development and branching of the portal vein with its surrounding mesenchyme [16] .
The 
Immunohistochemistry
All tissue specimens were routinely fixed in formalin and embedded in paraffin wax. Three-m thick tissue sections were mounted onto glass slides pretreated with 2% 3-aminopropyltriethoxysilane (APES, Sigma, Steinheim, Germany) and dried at 37ЊC overnight. The previously characterized immuno-purified anti-FP2 antiserum was used as described by Menezes et al. [6] . In addition, several antibodies were used to differentiate CCC from HCC ( (Fig. 2B and C Fig. 2C ). In three additional cases of BA with DPM at early (Fig. 2D) (Fig. 2H) showed a moderate diffuse staining of the ductular structures, whilst the hepatocytes showed a mild diffuse staining. In liver biopsies with paucity of the intrahepatic bile ducts (PIBD) (Fig. 3A) , intense, mild and no FP2 staining were found in two, nine and five cases, respectively. (Fig. 3B) (Fig. 3C) showed an intense staining of the biliary structures and periportal hepatocytes. In Caroli's disease (Fig. 3D) (Fig. 5A-D (Fig. 5B) (Fig. 5C ). In the same liver specimen, we could also detect FP2-staining with co-staining of the biliary structures with MUC-1 (Fig. 5D ). FP2 staining (anti-FP2, ϫ400) -FP2, ϫ200 and ϫ320 in the inset) . anti-FP2, ϫ400) . 
APO-LD (annular pancreas obstruction-associated liver disease), BA (biliary atresia), CC-LD (choledocal cyst-associated liver disease), CID NOS (congenital immunodeficiency, not otherwise specified), CHF (congenital hepatic fibrosis), CMV-H (cytomegalovirus hepatitis), CVD-HI (cardiovascular disease with hepatic involvement), DILD (drug-induced liver disease), FFAOD (fetal fatty acid oxidation disorder associated with maternal HELLP syndrome (hemolysis, elevated liver enzymes, low platelets), Gly-I (glycogenosis type I), NC NOS (neonatal cholestasis not otherwise specified), NH (neonatal hepatitis), PDHP-LD (liver disease associated with deficiency of pyruvate dehydrogenase phosphate), PIBD (paucity of intrahepatic bile ducts), NBLD NOS (nonbiliary liver disease not otherwise specified), NEC-LD (hepatic involvement associated with necrotizing enterocolitis), and WFASS (Wissler-Fanconi allergic subsepsis syndrome). S.D.: standard deviation, S.E.M.: standard error of the mean.
Antibody
Finally, a mild staining was found in single cases of sepsis, choledocal cyst-associated liver disease (CC-LD), annular pancreas obstruction-associated liver disease (APO-LD), cardiovascular disease with hepatic involvement (CVD-HI), FFAOD (foetal fatty acid oxidation disorder associated with maternal HELLP syndrome), drug-induced liver disease (DILD), non-biliary liver disease (NBLD NOS), and liver disease associated with necrotizing enterocolitis (NEC-LD) as well as in two cases of neonatal cholestasis not otherwise specified (NC NOS). An additional case of an infant with alpha-1-antitrypsin deficiency
Discussion
Research on bile duct disorders has recently directed efforts to explore a potential common pathogenetic pathway for hepatorenal fibrocystic syndromes (HFRC). In the last few years, the PKHD1 gene was found to be mutated in patients affected with ARPKD, a disease characterized by biliary dysgenesis and fusiform dilatations of the renal collecting ducts. This gene's product, polyductin, is expressed in kidney, liver, testis and pancreas, © 2009 The Authors Journal compilation © 2009 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Fig. 2 Polyductin expression in liver disease of newborns and infants. In (A), there is liver tissue with a baseline staining (anti-FP2, ϫ100) with no staining of the interlobular bile duct (arrow) (inset, anti-FP2, ϫ320); (B) and (C) show two examples of biliary atresia with ductular proliferation without ductal plate malformation at early (B) (the arrow points to a bile duct) and advanced (C) stage showing the ductular proliferation (arrowheads) of biliary atresia with a moderate
Fig. 4 Polyductin expression in adult hepatobiliary carcinomas. (A) is the microphotograph of a cholangiocellular carcinoma (CCC) showing a moderate to intense FP2 staining of the neoplastic epithelium (arrowheads) embedded in a dense stroma (anti-FP2, ϫ200); in (B) there is a moderate FP2 staining in another CCC (arrowheads) (anti-FP2, ϫ400); in (C) no FP2 staining is demonstrated in a hepatocellular carcinoma (HCC) with trabecular growth pattern (anti-FP2, ϫ100), (D) no FP2 staining is also observed in another HCC with pseudoglandular growth pattern (anti-FP2, ϫ200), and (E and F) show tumour tissue metastasis to the lung from the liver combining cholangiocarcinomatous and hepatocellular features and showing FP2 staining mostly in cholangiocarcinomatous cells (E) (arrowheads) (
CCC. We demonstrated that polyductin is expressed in human foetal
